|
|
| | Clindamycin 4-Phosphate Basic information |
| Product Name: | Clindamycin 4-Phosphate | | Synonyms: | Clindamycin 4-Phosphate;ClindaMycin 4-Phosphate
DISCONTINUED;OZDNESASKLVYBG-TXGWZQRJSA-N;(2R,3R,4R,5R,6R)-2-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-3-yl dihydrogen phosphate;Clindamycin Impurity 13(Clindamycin Phosphate EP Impurity D);Clindamycin phosphate Impurity D(Clindamycin 4-Phosphatediscontinued);Clindamycin EP Impurity D;Clindamycin Phosphate EP Impurity D/Clindamycin 4-Phosphate/methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]carbonyl]amino]-4-O-phosphono-1-thio-L-threo-α-D-galacto-octopyranoside | | CAS: | 54887-30-8 | | MF: | C18H34ClN2O8PS | | MW: | 504.96 | | EINECS: | 241-424-8 | | Product Categories: | Carbohydrates & Derivatives;Heterocycles;Impurities;Intermediates & Fine Chemicals;Pharmaceuticals;Phosphorylating and Phosphitylating Agents | | Mol File: | 54887-30-8.mol |  |
| | Clindamycin 4-Phosphate Chemical Properties |
| density | 1.41±0.1 g/cm3(Predicted) | | pka | 1.83±0.10(Predicted) |
| | Clindamycin 4-Phosphate Usage And Synthesis |
| Uses | Clindamycin (C580000) impurity. |
| | Clindamycin 4-Phosphate Preparation Products And Raw materials |
|